Overview

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Status:
Recruiting

Trial end date:
2022-08-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the treatment effectiveness of Adhansia XR at month-2 after initiation, and the effectiveness of Adhansia XR overall and when compared with the active comparator group (Concerta) over time.

Phase:

Phase 4

Details

Lead Sponsor:

Purdue Pharma LP

Treatments:

Methylphenidate